Prof. Heather Wakelee, Stanford University, USA
Prof. Yan Huang, Sun Yat-sen University Cancer Center, China
Host: Prof. Caicun Zhou, Department of Oncology, Shanghai East Hospital, China
Prof. Huang and Prof. Wakelee discussed the clinical value and current limitations of ctDNA as a biomarker in lung cancer, with a focus on its role in early response assessment, prognosis prediction, and treatment decision-making in the neoadjuvant and perioperative settings.